JP2007505050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505050A5 JP2007505050A5 JP2006525630A JP2006525630A JP2007505050A5 JP 2007505050 A5 JP2007505050 A5 JP 2007505050A5 JP 2006525630 A JP2006525630 A JP 2006525630A JP 2006525630 A JP2006525630 A JP 2006525630A JP 2007505050 A5 JP2007505050 A5 JP 2007505050A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- group
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims 4
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 2
- -1 hydroxy, aminocarbonyl Chemical group 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 0 **C(**)c1cc(C=O)n[o]1 Chemical compound **C(**)c1cc(C=O)n[o]1 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301323 | 2003-09-12 | ||
| US50310403P | 2003-09-15 | 2003-09-15 | |
| PCT/DK2004/000604 WO2005026133A1 (en) | 2003-09-12 | 2004-09-10 | Isoxazoles as peptide deformylase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505050A JP2007505050A (ja) | 2007-03-08 |
| JP2007505050A5 true JP2007505050A5 (enExample) | 2007-11-01 |
Family
ID=34315138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525630A Withdrawn JP2007505050A (ja) | 2003-09-12 | 2004-09-10 | ペプチドデホルミラーゼ阻害剤としてのイソキサゾール類 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1664000A1 (enExample) |
| JP (1) | JP2007505050A (enExample) |
| WO (1) | WO2005026133A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE532866T1 (de) * | 2006-08-02 | 2011-11-15 | Council Scient Ind Res | Peptiddeformylase als hilfsmittel zur entwicklung mykobakterien-spezifischer antisense- nukleinsäuremoleküle |
| EP2432776B1 (en) * | 2009-05-21 | 2019-09-11 | Universite Laval | Methyl sulfanyl pyrimidines useful as antiinflammatories, analgesics, and antiepileptics |
| GEP20156397B (en) | 2011-05-06 | 2015-11-10 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Process for the preparation of a rivaroxaban and intermediates formed in said process |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1134837A (en) * | 1979-10-05 | 1982-11-02 | Ronald G. Micetich | Alkylthioalkyl-isoxanzoles and -isoxazolines |
| DE3742266A1 (de) * | 1987-12-12 | 1989-06-22 | Basf Ag | 2-tert.-butyl-5-isoxazolylmethylthio-3(2h)-pyridazin-3-on-derivate |
| JP4220377B2 (ja) * | 2001-04-05 | 2009-02-04 | スミスクライン・ビーチャム・コーポレイション | ペプチドデホルミラーゼ阻害物質 |
-
2004
- 2004-09-10 JP JP2006525630A patent/JP2007505050A/ja not_active Withdrawn
- 2004-09-10 WO PCT/DK2004/000604 patent/WO2005026133A1/en not_active Ceased
- 2004-09-10 EP EP04762824A patent/EP1664000A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2488582C2 (ru) | Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение | |
| JP2011503099A5 (enExample) | ||
| JP2012506441A5 (enExample) | ||
| JP2006515858A5 (enExample) | ||
| JP2013542218A5 (enExample) | ||
| JP2010031025A5 (enExample) | ||
| WO2005046589A3 (en) | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties | |
| JP2014508811A5 (enExample) | ||
| JP2005517666A5 (enExample) | ||
| JP2010526025A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2008523069A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2010501478A5 (enExample) | ||
| JP2008505194A5 (enExample) | ||
| JP2012512863A5 (enExample) | ||
| JP2011519910A5 (enExample) | ||
| JP2011529502A5 (enExample) | ||
| JP2003535128A5 (enExample) | ||
| JP2005518351A5 (enExample) | ||
| JP2007502817A5 (enExample) | ||
| JP2005517643A5 (enExample) | ||
| PL378201A1 (pl) | Sposób farmaceutyczny oraz związki wytwarzane tym sposobem | |
| JP2023022236A5 (enExample) | ||
| JP2014518212A5 (ja) | 化合物及び組成物 |